cagrisema vs tirzepatide in Adults With or Without Diabetes β REDEFINE 1 & 2 β’ π Cagrilintide 2.4 mg + Semaglutide 2.4 mg once weekly β’ π β20.4% weight loss (non-diabetic) & β13.7% (T2D) obesitymedicine #medicalnews #clinicaltrials #cagrisema #zepbound
Description
Keep the vial in its original packaging or wrapped in foil to protect from light
PlexusDx's genetic pathway analysis helps determine whether you're a strong responder to GLP-1R signaling alone (favoring semaglutide) or if you have variants suggesting GIPR responsiveness (favoring tirzepatide acceleration)
GLP-1 is een natuurlijk darmhormoon dat de eetlust, de afgifte van insuline en de bloedsuikerspiegel reguleert (1,2)

Leakage after injection: A small amount of solution may sometimes leak back out

104:3077-3087 [PubMed: 30835263] 225
